Complete response and long-term survival of leptomeningeal carcinomatosis from breast cancer with maintenance endocrine therapy

MM Almajed, K Esfahani, M Pelmus… - Case Reports, 2016 - casereports.bmj.com
Leptomeningeal carcinomatosis carries a poor prognosis in breast cancer. Treatment
modalities are geared towards tumour molecular characteristics, as well as symptoms and …
被引用次数：9 相关文章

Complete response and long-term survival of leptomeningeal carcinomatosis from breast cancer with maintenance endocrine therapy

MM Almajed, K Esfahani, M Pelmus… - BMJ case …, 2016 - pubmed.ncbi.nlm.nih.gov
Leptomeningeal carcinomatosis carries a poor prognosis in breast cancer. Treatment
modalities are geared towards tumour molecular characteristics, as well as symptoms and …

Complete response and long-term survival of leptomeningeal carcinomatosis from breast cancer with maintenance endocrine therapy.

MM Almajed, K Esfahani, M Pelmus, L Panasci - BMJ Case Reports, 2016 - europepmc.org
Leptomeningeal carcinomatosis carries a poor prognosis in breast cancer. Treatment
modalities are geared towards tumour molecular characteristics, as well as symptoms and …

Complete response and long-term survival of leptomeningeal carcinomatosis from breast cancer with maintenance endocrine therapy

MM Almajed, K Esfahani, M Pelmus… - BMJ Case …, 2016 - search.proquest.com
Leptomeningeal carcinomatosis carries a poor prognosis in breast cancer. Treatment
modalities are geared towards tumour molecular characteristics, as well as symptoms and …

Complete response and long-term survival of leptomeningeal carcinomatosis from breast cancer with maintenance endocrine therapy.

MM Almajed, K Esfahani, M Pelmus, L Panasci - BMJ Case Reports, 2016 - europepmc.org
Leptomeningeal carcinomatosis carries a poor prognosis in breast cancer. Treatment
modalities are geared towards tumour molecular characteristics, as well as symptoms and …